Journal of Cancer Research and Clinical Oncology,
Год журнала:
2024,
Номер
150(6)
Опубликована: Июнь 4, 2024
Abstract
Background
Butyrate
is
a
common
short-chain
fatty
acids
(SCFA),
and
it
has
been
demonstrated
to
regulate
the
development
of
breast
cancer
(BC),
while
underlying
mechanism
still
unreported.
Methods
Gas
chromatography
was
used
measure
amounts
SCFA
(acetate,
propionate,
butyrate)
in
feces.
Cell
viability
measured
by
CCK-8
assay.
The
wound
healing
assay
cell
migration,
transwell
invasion.
levels
protein
gene
were
determined
western
blot
RT-qPCR
assay,
respectively.
Results
lower
faecal
samples
from
BC
patients
compared
control
samples.
In
cellular
experiments,
butyrate
significantly
suppressed
viability,
migration
invasion
T47D
dose-dependent
manner.
animal
effectively
impeded
growth
tumors.
Toll
like
receptor
4
(TLR4)
highly
expressed
tumors
patients.
inhibited
expression
TLR4.
addition,
promoted
cuproptosis-related
genes
including
PDXK
(pyridoxal
kinase)
SLC25A28
(solute
carrier
family
25
member
28),
which
lowly
Importantly,
overexpression
TLR4
can
reverses
promotion
prevention
malignant
biological
behaviors
cells.
Conclusion
summary,
inhibits
facilitating
through
inhibition
Our
investigation
first
identified
connection
among
butyrate,
progression.
These
findings
may
provide
novel
target
for
treatment
BC.
Nutrients,
Год журнала:
2023,
Номер
15(9), С. 2211 - 2211
Опубликована: Май 6, 2023
Short-chain
fatty
acids
(SCFAs)
play
a
key
role
in
health
and
disease,
as
they
regulate
gut
homeostasis
their
deficiency
is
involved
the
pathogenesis
of
several
disorders,
including
inflammatory
bowel
diseases,
colorectal
cancer,
cardiometabolic
disorders.
SCFAs
are
metabolites
specific
bacterial
taxa
human
microbiota,
production
influenced
by
foods
or
food
supplements,
mainly
prebiotics,
direct
fostering
these
taxa.
This
Review
provides
an
overview
SCFAs’
roles
functions,
SCFA-producing
bacteria,
from
microbiological
characteristics
taxonomy
to
biochemical
process
that
lead
release
SCFAs.
Moreover,
we
will
describe
potential
therapeutic
approaches
boost
levels
treat
different
related
diseases.
Nutrients,
Год журнала:
2023,
Номер
15(2), С. 356 - 356
Опубликована: Янв. 11, 2023
The
current
study
aims
to
evaluate
the
potential
roles
of
taking
probiotics
postoperatively
in
attenuating
gastrointestinal
complications
and
disturbed
gut
microbiota
colorectal
cancer
(CRC)
patients
undergoing
chemotherapy.
One
hundred
eligible
CRC
who
were
treated
with
radical
surgery
needed
receive
chemotherapy
recruited.
Half
them
randomly
assigned
Probio
group
take
a
probiotic
combination
from
post-operation
end
first
chemotherapeutic
course.
other
half
placebo
instead
classified
as
Placebo
group.
Gastrointestinal
such
nausea,
acid
reflux,
abdominal
pain,
distention,
constipation,
diarrhea
recorded
during
Fecal
samples
collected
preoperatively
after
cycle
postoperative
for
16S
rRNA
high-throughput
sequencing
short-chain
fatty
acids
(SCFAs)
analysis.
Results
showed
that
administration
could
effectively
reduce
chemotherapy-induced
complications,
particularly
(p
<
0.01).
Additionally,
also
reduced
bacterial
diversity
indexes
patients,
which
be
significantly
increased
by
probiotics.
Moreover,
this
caused
significant
changes
composition
microbiota,
indicated
decreased
phylum
levels
Firmicutes
Bacteroidetes,
Proteobacteria,
Verrucomicrobia.
In
particular,
several
genera
Akkermansia
Clostridium
increased,
while
Prevotella,
Lactobacillus,
Roseburia
0.05).
However,
restore
these
taxa
both
at
genus
levels,
mildly
increase
Bifidobacterium,
Streptococcus,
Blautia.
Furthermore,
promote
production
SCFAs,
increasing
acetate,
butyrate,
propionate
0.0001).
These
results
support
beneficial
effects
interventions
novel
alternative
or
complementary
strategies
chemoprevention.
Gastroenterology,
Год журнала:
2023,
Номер
164(7), С. 1069 - 1085
Опубликована: Фев. 24, 2023
The
human
gut
microbiome
has
been
linked
to
numerous
digestive
disorders,
but
its
metabolic
products
have
much
less
well
characterized,
in
part
due
the
expense
of
untargeted
metabolomics
and
lack
ability
process
data.
In
this
review,
we
focused
on
rapidly
expanding
information
about
bile
acid
repertoire
produced
by
microbiome,
including
impacts
acids
a
wide
range
host
physiological
processes
diseases,
discussed
role
short-chain
fatty
other
important
microbiome-derived
metabolites.
Of
particular
note
is
action
metabolites
throughout
body,
which
impact
ranging
from
obesity
aging
disorders
traditionally
thought
as
diseases
nervous
system,
that
are
now
recognized
being
strongly
influenced
it
produces.
We
also
highlighted
emerging
for
modifying
improve
health
or
treat
disease,
"engineered
native
bacteria''
approach
takes
bacterial
strains
patient,
modifies
them
alter
metabolism,
reintroduces
them.
Taken
together,
study
derived
provided
insights
into
pathophysiological
processes,
substantial
potential
new
approaches
diagnostics
therapeutics
disease
of,
involving,
gastrointestinal
tract.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(13), С. 10672 - 10672
Опубликована: Июнь 26, 2023
Endocrine
homeostasis
and
metabolic
diseases
have
been
the
subject
of
extensive
research
in
recent
years.
The
development
new
techniques
insights
has
led
to
a
deeper
understanding
mechanisms
underlying
these
conditions
opened
up
avenues
for
diagnosis
treatment.
In
this
review,
we
discussed
rise
diseases,
especially
Western
countries,
genetical,
psychological,
behavioral
basis
role
nutrition
physical
activity
single-cell
transcriptomics,
gut
microbiota,
epigenetics,
advanced
imaging
techniques,
cell-based
therapies
diseases.
Finally,
practical
applications
derived
from
information
are
made.
Colorectal
cancer
(CRC)
is
the
third
most
common
malignant
tumor
worldwide.
The
incidence
and
mortality
rates
of
CRC
have
been
increasing
in
China,
possibly
due
to
economic
development,
lifestyle,
dietary
changes.
Evidence
suggests
that
gut
microbiota
plays
an
essential
role
tumorigenesis
CRC.
Gut
dysbiosis,
specific
pathogenic
microbes,
metabolites,
virulence
factors,
microbial
carcinogenic
mechanisms
contribute
initiation
progression
biomarkers
potential
translational
applications
screening
early
diagnosis.
microbiota-related
interventions
could
improve
anti-tumor
therapy's
efficacy
severe
intestinal
toxic
effects.
Chinese
researchers
made
many
achievements
relationship
between
CRC,
although
some
challenges
remain.
This
review
summarizes
current
evidence
from
China
on
mainly
including
characteristics,
especially
Fusobacterium
nucleatum
Parvimonas
micra,
which
identified
be
enriched
patients;
pathogens
such
as
F.
enterotoxigenic
Bacteroides
fragilis,
P.
scientists
extensively
studied;
diagnostic
nucleatum;
therapeutic
effects,
microecological
agents
represented
by
certain
Lactobacillus
strains,
fecal
transplantation,
traditional
medicines
Berberine
Curcumin.
More
efforts
should
focused
exploring
underlying
pathogenesis
providing
novel
preventive
strategies.
Cell Death Discovery,
Год журнала:
2025,
Номер
11(1)
Опубликована: Фев. 26, 2025
Abstract
Colorectal
cancer
(CRC)
is
the
third
most
common
malignancy
globally
and
second
leading
cause
of
cancer-related
mortality.
Its
development
a
multifactorial
multistage
process
influenced
by
dynamic
interplay
between
gut
microbiota,
environmental
factors,
fatty
acid
metabolism.
Dysbiosis
intestinal
microbiota
abnormalities
in
microbiota-associated
metabolites
have
been
implicated
colorectal
carcinogenesis,
highlighting
pivotal
role
microbial
metabolic
interactions.
Fatty
metabolism
serves
as
critical
nexus
linking
dietary
patterns
with
activity,
significantly
impacting
health.
In
CRC
patients,
reduced
levels
short-chain
acids
(SCFAs)
SCFA-producing
bacteria
consistently
observed.
Supplementation
probiotics
has
demonstrated
tumor-suppressive
effects,
while
therapeutic
strategies
aimed
at
modulating
SCFA
shown
potential
enhancing
efficacy
radiation
therapy
immunotherapy
both
preclinical
clinical
settings.
This
review
explores
intricate
relationship
metabolism,
CRC,
offering
insights
into
underlying
mechanisms
their
translational
applications.
Understanding
this
could
pave
way
for
novel
diagnostic,
therapeutic,
preventive
management
CRC.
Pharmacological Research,
Год журнала:
2022,
Номер
182, С. 106321 - 106321
Опубликована: Июнь 22, 2022
The
role
of
gut
microbiota
in
regulating
the
intestinal
homeostasis,
as
well
pathogenesis
severe
acute
pancreatitis-associated
lung
injury
(PALI)
is
widely
recognized.
bioactive
functions
metabolites
with
small
molecule
weight
and
detail
molecular
mechanisms
PALI
mediated
by
"gut-lung
axis"
have
gradually
raised
attentions
researchers.
Several
studies
proved
that
short-chain
fatty
acids
(SCFAs)
produced
microbiome
play
crucial
roles
varied
activities
process
PALI.
However,
relevant
reviews
reporting
SCFAs
involvement
lacking.
In
this
review,
we
firstly
introduced
synthetic
metabolic
pathways
SCFAs,
transport
signal
transduction
routes
brief.
Afterwards,
focused
on
possible
clues
to
participate
fight
against
which
referred
inhibition
pathogen
proliferation,
anti-inflammatory
effects,
enhancement
barrier
functions,
maintenance
regulation
immune
homeostasis
via
pathogen-associated
patterns
(PAMPs)
damage-associated
(DAMPs).
addition,
latest
reported
pathological
physiological
gut-lung
axis
involved
were
reviewed.
Finally,
summarized
potential
therapeutic
interventions
targeting
including
dietary
fiber
supplementation,
direct
supplementation
SCFAs/prebiotics/probiotics,
drugs
administration,
expected
provide
new
sights
for
clinical
use
future.